Revolution Medicines

ISIN US76155X1000

 | 

WKN A2PYWG

Market cap (in EUR)
17,795 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Show more Show less
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 17,795 m
EPS, EUR -4.69
P/B ratio 12.8
P/E ratio -
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR -
Net income, EUR -555 m
Profit margin -

What ETF is Revolution Medicines in?

There are 4 ETFs which contain Revolution Medicines. All of these ETFs are listed in the table below. The ETF with the largest weighting of Revolution Medicines is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.95%
Equity
United States
Health Care
Biotech
46
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
495
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.02%
Equity
North America
Social/Environmental
27
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.15%
Equity
United States
Small Cap
182
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.